Protalix BioTherapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $5.4M | $-3.4M | $52.0M |
| FY2013 | $2.4M | $-26.9M | $86.4M |
| FY2014 | $912.0K | $-55.6M | $54.8M |
| FY2015 | — | $10.9M | $76.4M |
| FY2016 | — | $-10.0M | $63.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | $5.4M | $-3.4M | $52.0M |
| FY2013 | $2.4M | $-26.9M | $86.4M |
| FY2014 | $912.0K | $-55.6M | $54.8M |
| FY2015 | — | $10.9M | $76.4M |
| FY2016 | — | $-10.0M | $63.3M |